Home NDC 73399-001 Formula 1
Product NDC 73399-001
11-digit product format 733990001
Labeler code 73399
Product ID 73399-001_8884d1f0-cace-4c1c-86cb-d344962a164e
Type HUMAN OTC DRUG
Nonproprietary name ATP, Adeps suillus, Adrenal cortex suis, Alpha ketoglutaricum acidum, Cerebrum suis, Coenzyme A, Colon suis, Duodenum suis, Fel suis, Fel tauri, Fumaricum acidum, Glandula thyreoidea suis, Hepar suis, Hypothalamus suis, lleum suis, Jejunum suis, Malicum acidum, Methylglyoxal, Oxalaldehyde, Pancreas suis, Pituitary gland suis, Ventriculus
Dosage form LIQUID
Route ORAL
Labeler 20Lighter, LLC.
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2020-01-29
Marketing end 0000-00-00
Substance ADENOSINE TRIPHOSPHATE; LARD; SUS SCROFA CEREBRUM; COENZYME A; SUS SCROFA COLON; SUS SCROFA DUODENUM; BOS TAURUS BILE; FUMARIC ACID; THYROID, PORCINE; PORK LIVER; BOS TAURUS HYPOTHALAMUS; PYRUVALDEHYDE; GLYOXAL; SUS SCROFA PANCREAS
Active strength 30 [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 18 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 73399-001-30 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 73399-001-30 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 73399-001-30 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 73399-001-30 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 73399-001-30 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 73399-001-30 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 73399-001-30 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 73399-001-30 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 73399-001-30 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 73399-001-30 Formula 1 30 mL in 1 BOTTLE LIQUID 30 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 73399-001 FORMULA 1 (ATP, ADEPS SUILLUS, ADRENAL CORTEX SUIS, ALPHA KETOGLUTARICUM ACIDUM, CEREBRUM SUIS, COENZYME A, COLON SUIS, DUODENUM SUIS, FEL SUIS, FEL TAURI, FUMARICUM ACIDUM, GLANDULA THYREOIDEA SUIS, HEPAR SUIS, HYPOTHALAMUS SUIS, LLEUM SUIS, JEJUNUM SUIS, MALICUM ACIDUM, METHYLGLYOXAL, OXALALDEHYDE, PANCREAS SUIS, PITUITARY GLAND SUIS, VENTRICULUS) LIQUID [20LIGHTER, LLC.] 3 Legacy NDC, 1 package rows 20211116_8d14b8ca-268e-4db2-86fb-6427ad6bf9f3.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 73399-001-30 73399000130 30 mL in 1 BOTTLE (73399-001-30) 30 ml 2020-01-29 0000-00-00 No No Current